HighLife announced that it received FDA breakthrough device designation for its trans-septal mitral valve replacement (TMVR) ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

TRILUMINATE's primary endpoint was a hierarchical composite of death from any cause or tricuspid valve surgery, ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...

Ben McCullough met the 25 Edwards Lifesciences technicians who spent 20 hours hand-sewing 2,000 stitches to make a valve ...

Dear K.T.: Dexfenfluramine, aka Redux (also called "fen-phen" in combination with phentermine), was sold in the 1990s until ...

Abbott (NYSE: ABT) today announced late-breaking data from its TRILUMINATE™ Pivotal trial that show the TriClip™ transcatheter edge-to-edge repair (TEER) system to treat tricuspid regurgitation (TR), ...

Varanasi: An 18-year-old boy with a complex congenital cardiac abnormality was operated on successfully in the ...